NOV Inc. Stock
We can see a decrease in the price for NOV Inc.. Compared to yesterday it has lost -€0.270 (-1.570%).
Currently there is a rather positive sentiment for NOV Inc. with 19 Buy predictions and 4 Sell predictions.
On the other hand, the target price of 16 € is below the current price of 16.98 € for NOV Inc., so the potential is actually -5.74%.
Our community identified positive and negative aspects for NOV Inc. stock for the coming years. 1 users see the criterium "Balance Sheet Risk" as a plus for the NOV Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of NOV Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of NOV Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| NOV Inc. | -1.570% | 6.979% | 9.666% | 19.924% | 30.053% | -13.775% | 44.008% |
| SBM Offshore N.V. | -0.320% | 3.877% | 2.304% | 49.136% | 26.857% | 119.337% | 101.753% |
| Cimc Enric Holdings Inc. | 0.000% | 0.000% | 17.431% | 56.098% | 32.642% | 35.378% | 134.862% |
| Core Laboratories Inc. | -1.290% | 0.000% | -6.627% | -3.125% | 13.971% | -26.540% | -46.918% |
Comments
NOV (NYSE:NOV) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for NOV provided by MarketBeat
NOV (NYSE:NOV) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for NOV provided by MarketBeat
NOV (NYSE:NOV) had its price target raised by analysts at TD Cowen from $19.00 to $22.00. They now have a "buy" rating on the stock.
Show more
Ratings data for NOV provided by MarketBeat
News
This Fund Put 22% of Assets Into an Oilfield Equipment Stock Up 25% in a Year
London-based Oldfield Partners increased its stake in NOV (NYSE:NOV) by 276,961 shares in the fourth quarter, an estimated $4.11 million trade based on quarterly average pricing, according to a
